当前位置： SCI文献检索 > EUROPEAN UROLOGY期刊下所有文献 > Superficial bladder cancer: survival and prognostic factors.

Superficial bladder cancer: survival and prognostic factors.

Abstract：

:Two hundred and seventeen consecutive patients with superficial bladder cancer stages Ta-T1 were analyzed for survival and prognostic factors. The overall 5-year survival was 88 +/- 5.3%. Factors that impacted significantly on survival were: grade of anaplasia (GI 92 +/- 5.9% vs. GII 87 +/- 7.5% vs. GIII 68 +/- 20.7%; p = 0.01); increasing grade of anaplasia (98 +/- 1.9% vs. 55 +/- 15.6%; p less than 0.0001); progression in tumor stage (100% vs. 58 +/- 12.5%; p less than 0.0001); index of recurrences greater than 0.7 (100% vs. 71 +/- 10%; p less than 0.0001); the presence of urothelial dysplasia (98 +/- 1.7% vs. 77 +/- 9.8%; p less than 0.05); inflammatory infiltrate (90 +/- 7% vs. 83 +/- 7.3%; p less than 0.01), and residual tumor post-TUR (89 +/- 5.5% vs. 68 +/- 18.6%; p less than 0.001). Tumor stage did not impact on survival (p greater than 0.05). Using multivariate statistical analysis only the grade of anaplasia (p less than 0.0001) and increasing grade of anaplasia (p = 0.001) demonstrated significant prognostic value. Eight percent of patients died because of tumor progression. Of these patients, 87% were T1 and had concomitant urothelial dysplasia. Twenty-five percent had carcinoma in situ and the mean index of recurrence was 1.59. Seventy-five percent of patients dying because of tumor progression developed muscle-infiltrating cancer (greater than or equal to T2GIII) and 25% developed previously metastatic spread without evidence of local progression (T1GIII).(ABSTRACT TRUNCATED AT 250 WORDS)

journal_name

Eur Urol

journal_title

European urology

authors

Sánchez de la Muela P,Rosell D,Agüera L,De Castro F,Isa W,Robles JE,Zudaire JJ,Berián JM

doi

10.1159/000471697

subject

Has Abstract

pub_date

1991-01-01 00:00:00

pages

184-91

issue

3

eissn

0302-2838

issn

1873-7560

journal_volume

20

pub_type

杂志文章

相关文献

EUROPEAN UROLOGY文献大全
  • Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time.

    abstract：:To estimate the growth rate of prostate cancer, the doubling times of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) were determined in 51 patients: 44 were refractory to endocrine therapy, and 7 were in an untreated state. Since an exponential increase in PSA and PAP was observed in all patients...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000475162

    authors： Akimoto S,Masai M,Akakura K,Shimazaki J

    更新日期：1995-01-01 00:00:00

  • Association of smoking with urgency in older people.

    abstract：OBJECTIVE:To evaluate the association of smoking with urgency in older people. METHODS:A population-based survey involving 1,059 people aged 60-89 years. A stratified sampling method was used and data were collected by interviews. The response rate was 82%. The indicators were urgency, former and current smoking, alco...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000049774

    authors： Nuotio M,Jylhä M,Koivisto AM,Tammela TL

    更新日期：2001-08-01 00:00:00

  • The place of acupuncture in the management of psychogenic impotence.

    abstract：:Successful sexual functioning is a complex process involving psychological and social responses as well as neurological, biochemical and vascular processes. Today it is believed that more than 50% of the sexual dysfunction cases have an organic etiology. Reflecting the controversy over the management of psychogenic im...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1159/000475342

    authors： Yaman LS,Kiliç S,Sarica K,Bayar M,Saygin B

    更新日期：1994-01-01 00:00:00

  • Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

    abstract：CONTEXT:The outcome prediction for renal cell cancer (RCC) remains controversial, and although many parameters have been tested for prognostic significance, only a few have achieved widespread acceptance in clinical practice. The TNM staging system defines local extension of the primary tumour (T), involvement of regio...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2009.06.036

    authors： Moch H,Artibani W,Delahunt B,Ficarra V,Knuechel R,Montorsi F,Patard JJ,Stief CG,Sulser T,Wild PJ

    更新日期：2009-10-01 00:00:00

  • Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.

    abstract：OBJECTIVE:To evaluate the diagnostic utility of free prostate specific antigen (fPSA), alpha-1- antichymotrypsin-bound PSA (PSA-ACT), complexed PSA (cPSA), and including their associated ratios to total PSA (tPSA) in serum for discrimination between prostate cancer (PCa) and benign prostatic hyperplasia (BPH). METHODS...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000052413

    authors： Lein M,Jung K,Elgeti U,Petras T,Stephan C,Brux B,Sinha P,Winkelmann B,Schnorr D,Loening S

    更新日期：2001-01-01 00:00:00

  • Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.

    abstract：BACKGROUND:Chronic kidney disease (CKD) can be associated with a higher risk of progression to end-stage renal disease and mortality, but the etiology of nephron loss may modify this. Previous studies suggested that CKD primarily due to surgical removal of nephrons (CKD-S) may be more stable and associated with better ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2015.04.043

    authors： Lane BR,Demirjian S,Derweesh IH,Takagi T,Zhang Z,Velet L,Ercole CE,Fergany AF,Campbell SC

    更新日期：2015-12-01 00:00:00

  • An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.

    abstract：:Serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) were evaluated with double monoclonal radioimmunoassays. In 250 patients with prostatic cancer the normal limits were as follows: PSA 0.1-2.7 ng/ml, and PAP 1.09 +/- 0.45 ng/ml (mean +/- SD). In 91 untreated patients with non-metastatic tumour...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472596

    authors： Siddall JK,Cooper EH,Newling DW,Robinson MR,Whelan P

    更新日期：1986-01-01 00:00:00

  • A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.

    abstract：CONTEXT:Overexpression of immune checkpoint molecules affects tumor-specific T-cell immunity in the cancer microenvironment, and can reshape tumor progression and metastasis. Antibodies targeting checkpoints could restore antitumor immunity by blocking the inhibitory receptor-ligand interaction. OBJECTIVE:To analyze d...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2015.02.032

    authors： Carosella ED,Ploussard G,LeMaoult J,Desgrandchamps F

    更新日期：2015-08-01 00:00:00

  • The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners.

    abstract：BACKGROUND:The development of the Treatment Satisfaction Scale (TSS) was previously reported (Kubin et al., 2004). OBJECTIVE:This article describes the psychometric validation process and psychometric properties (e.g., reliability, validity, and responsiveness) of TSS. METHODS:Initial patient and partner questionnair...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2005.05.008

    authors： DiBenedetti DB,Gondek K,Sagnier PP,Kubin M,Marquis P,Keininger D,Fugl-Meyer AR

    更新日期：2005-09-01 00:00:00

  • Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.

    abstract：BACKGROUND:Phosphodiesterase type 5 inhibitor (PDE5i) use is common for management of erectile dysfunction. Single-institution studies have reported conflicting data on the relationship between PDE5i use and biochemical recurrence of prostate cancer (BCR) after radical prostatectomy. OBJECTIVE:To evaluate the associat...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2015.12.013

    authors： Loeb S,Folkvaljon Y,Robinson D,Schlomm T,Garmo H,Stattin P

    更新日期：2016-11-01 00:00:00

  • A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.

    abstract：BACKGROUND:Primary culture and animal and cell-line models of prostate and bladder development have limitations in describing human biology, and novel strategies that describe the full spectrum of differentiation from foetal through to ageing tissue are required. Recent advances in biology demonstrate that direct repro...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2013.03.054

    authors： Moad M,Pal D,Hepburn AC,Williamson SC,Wilson L,Lako M,Armstrong L,Hayward SW,Franco OE,Cates JM,Fordham SE,Przyborski S,Carr-Wilkinson J,Robson CN,Heer R

    更新日期：2013-11-01 00:00:00

  • Evidence for eosinophil activation in eosinophilic cystitis.

    abstract：:Eosinophilic cystitis (EC) is a rare condition. Recent studies have shown that activated eosinophils release cytotoxic cationic proteins which can induce tissue damage. Moreover, in vitro studies have shown that interleukin-5 (IL-5) is a cytokine able to attract and activate eosinophils. The goal of this study was to ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000475293

    authors： Dubucquoi S,Janin A,Desreumaux P,Rigot JM,Copin MC,François M,Torpier G,Capron M,Gosselin B

    更新日期：1994-01-01 00:00:00

  • Urethra reconstruction following resection of penile leiomyosarcoma.

    abstract：:Leiomyosarcoma is a rare tumor, particularly in genital area. We present a case of penile lyomyosarcoma. Surgical treatment involved subcutaneous penectomy, preserving a sensate skin envelope, bilateral groin dissection and perineal urethrostomy. Reconstruction of the urethra and soft tissue was carried out using a fr...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2006.02.013

    authors： Dabernig J,Schumacher O,Shelley OP,Dabernig W,Schaff J

    更新日期：2006-06-01 00:00:00

  • Follow-up in prostate cancer patients: which parameters are necessary?

    abstract：AIM:In a retrospective study we examined whether follow-up of prostate cancer (PC) patients can be managed by using prostate-specific antigen (PSA) as a unique tool as postulated recently. PATIENTS AND METHODS:According to strict criteria established in the eighties, at our institution PC patients were monitored by PS...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000019814

    authors： Strohmaier WL,Keller T,Bichler KH

    更新日期：1999-01-01 00:00:00

  • A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

    abstract：CONTEXT:Several randomized controlled trials (RCTs) on phosphodiesterase type 5 inhibitors (PDE5-Is) have showed significant improvements in both lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) in men affected by one or both conditions, without a significant increase in adverse events. However, the re...

    journal_title：European urology

    pub_type： 杂志文章,meta分析,评审

    doi：10.1016/j.eururo.2012.02.033

    authors： Gacci M,Corona G,Salvi M,Vignozzi L,McVary KT,Kaplan SA,Roehrborn CG,Serni S,Mirone V,Carini M,Maggi M

    更新日期：2012-05-01 00:00:00

  • Importance of individual response in symptom score evaluation.

    abstract：:In making treatment decisions for patients with benign prostatic hyperplasia (BPH), physicians have to rely on the efficacy data published in the literature and adapt this to individual patient's needs. Criticism can be made, however, of the randomised clinical trials (RCTs) that are performed, as the patients enrolle...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1159/000049884

    authors： Desgrandchamps F

    更新日期：2001-01-01 00:00:00

  • Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.

    abstract：CONTEXT:Previous studies have reported significant variation in prostate cancer rates and trends mainly due to differences in detection practices, availability of treatment, and underlying genetic susceptibility. OBJECTIVE:To assess recent worldwide prostate cancer incidence, mortality rates, and trends using up-to-da...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2019.08.005

    authors： Culp MB,Soerjomataram I,Efstathiou JA,Bray F,Jemal A

    更新日期：2020-01-01 00:00:00

  • Urinary incontinence in Belgium: a population-based epidemiological survey.

    abstract：OBJECTIVE:To investigate the prevalence, typology, and experience of urinary incontinence, as well as the available therapeutic modalities and information sources among people living at home in Belgium. METHODS:A representative population sample of 5,269 adults completed a questionnaire in their own homes. There were ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：

    authors： Schulman C,Claes H,Matthijs J

    更新日期：1997-01-01 00:00:00

  • Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.

    abstract：BACKGROUND:Relatively little is known about the relationship between race/ethnicity and patient-reported outcomes after contemporary treatments for localized prostate cancer. OBJECTIVE:To test the hypothesis that treatment-related changes in urinary, bowel, sexual, and hormonal function vary by race/ethnicity. DESIGN...

    journal_title：European urology

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.eururo.2016.10.036

    authors： Tyson MD,Alvarez J,Koyama T,Hoffman KE,Resnick MJ,Wu XC,Cooperberg MR,Goodman M,Greenfield S,Hamilton AS,Hashibe M,Paddock LE,Stroup A,Chen VW,Penson DF,Barocas DA

    更新日期：2017-08-01 00:00:00

  • Clinical application of the Bardex IC Foley catheter.

    abstract：OBJECTIVES:We performed two randomized prospective studies with the silver-coated Bardex IC catheter in order to evaluate the incidence of bacteriuria during short- and medium-term catheterization after urological procedures. METHODS:During catheterization only consecutive suprapubic urine samples were taken and cultu...

    journal_title：European urology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1159/000068005

    authors： Verleyen P,De Ridder D,Van Poppel H,Baert L

    更新日期：1999-09-01 00:00:00

  • Villous adenoma of the prostatic urethra.

    abstract：:We present a case of villous adenoma of the prostatic urethra, without malignant transformation. A review of the diagnostic and therapeutic criteria and pathogenic hypotheses on this kind of lesion in the lower urinary tract are made. ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472952

    authors： Algaba F,Matias-Guiu X,Badia F,Solé-Balcells F

    更新日期：1988-01-01 00:00:00

  • Immunologic aspect of testicular torsion: detection of antisperm antibodies in contralateral testicle.

    abstract：OBJECTIVE:To evaluate the immunologic etiology in unilateral testicular torsion, an experimental study in rats was carried out. MATERIALS AND METHODS:75 adult Wistar rats included in the study program were divided into six different groups according to a torsion-detorsion procedure. Torsion degree was kept constant fo...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000020060

    authors： Koşar A,Küpeli B,Alçigir G,Ataoglu H,Sarica K,Küpeli S

    更新日期：1999-12-01 00:00:00

  • The 72nd codon change of p53 in primary renal cell carcinoma was confirmed as a polymorphism among Japanese.

    abstract：OBJECTIVE:The role of p53 mutation in renal cell carcinoma (RCC) is not fully understood particularly among Japanese, although frequent loss of heterozygosity (LOH) has been demonstrated at polymorphic exon 4. METHODS:We examined the p53 gene in 43 primary RCC samples by polymerase chain reaction-single strand conform...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000474423

    authors： Kageyama Y,Yamamura Y,Oshima H,Ikawa Y

    更新日期：1997-01-01 00:00:00

  • Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate.

    abstract：:A comparative retrospective study was performed on 100 patients who had undergone transurethral resection of a superficial bladder tumor (Ta-Tl) with no associated carcinoma in situ (group 1) and 100 patients who had undergone simultaneous transurethral resection of a superficial bladder tumor (Ta-Tl), with no associa...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000473392

    authors： Vicente J,Chéchile G,Pons R,Méndez G

    更新日期：1988-01-01 00:00:00

  • Management of ureteric stones.

    abstract：:Based on experience with over 2,000 patients, the treatment of ureteric stones today relies on extracorporeal shock wave lithotripsy (ESWL) in situ and ureteroscopy with semirigid, ultrathin ureteroscopes combined with pneumatic or laser lithotripsy. All stones in the upper and larger stones in the distal third of the...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1159/000475300

    authors： Marberger M,Hofbauer J,Türk C,Höbarth K,Albrecht W

    更新日期：1994-01-01 00:00:00

  • Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.

    abstract：BACKGROUND:Conventional gray scale ultrasound has a low sensitivity and specificity for prostate cancer detection. Better imaging modalities are needed. OBJECTIVE:To determine sensitivity and specificity for prostate cancer detection with ultrasound-based real-time elastography (elastography) in patients scheduled for...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2008.02.035

    authors： Salomon G,Köllerman J,Thederan I,Chun FK,Budäus L,Schlomm T,Isbarn H,Heinzer H,Huland H,Graefen M

    更新日期：2008-12-01 00:00:00

  • Immortalisation of normal human urothelial cells compromises differentiation capacity.

    abstract：BACKGROUND:The development of urothelial malignancy is not solely a consequence of loss of proliferation constraints but also involves loss of cellular differentiation, defined histopathologically as grade. Although tumour grade is an independent prognostic marker for urothelial carcinoma (UC), the molecular events und...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2011.02.022

    authors： Georgopoulos NT,Kirkwood LA,Varley CL,MacLaine NJ,Aziz N,Southgate J

    更新日期：2011-07-01 00:00:00

  • Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.

    abstract：OBJECTIVE:The aim of this study was to compare the efficacy or transurethral resection of the prostate (TURP) versus four less invasive treatment options during a 2-year follow-up. MATERIAL AND METHODS:95 elderly men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) were assigned prospectivel...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1159/000020220

    authors： Schatzl G,Madersbacher S,Djavan B,Lang T,Marberger M

    更新日期：2000-06-01 00:00:00

  • How prenatal ultrasound can affect the treatment of ureterocele in neonates and children.

    abstract：:Prenatal ultrasound has set the stage for new trends in the diagnosis and treatment of many urinary tract malformations, in particular duplication of the renal collecting system with ureterocele. The authors have reviewed their experience with 41 ureteroceles in 7 years. The 36 patients were divided into two groups: t...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000471568

    authors： Caione P,Zaccara A,Capozza N,De Gennaro M

    更新日期：1989-01-01 00:00:00

  • Nanotechnology and its relevance to the urologist.

    abstract：OBJECTIVES:We review important aspects of nanotechnology, and discuss the wide range of research and clinical applications of nanomedicine in the field of urology. There is particular emphasis on key clinical and pre-clinical studies to provide an update on recent and potential applications in the care of urological pa...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2007.04.065

    authors： Gommersall L,Shergill IS,Ahmed HU,Hayne D,Arya M,Patel HR,Hashizume M,Gill IS

    更新日期：2007-08-01 00:00:00